🚨Just published! #Glutathione deficiency and #heartfailure: a systematic review of human and animal evidence is now out in Advances in #RedoxResearch!
This was a herculean effort in both writing and publication — grateful to see it out in the world. 🙌
https://t.co/HxwPVJFeHX
Great work by @F_Deiman and @CardiologyUmcg -team on the DECIPHER-PLN cohort! The extensive collection of biological samples covering the disease spectrum is a major step toward better understanding and combating PLN disease onset and progression. #Cardiology@researchumcg
Want to make a real difference in the lives of people with #cardiovascular diseases? Apply now and help shape the future of cardiac care! We are looking for a dedicated #PhD candidate with experience in cell and animal models, or keen interest in (big) data analyses.
The #DECISION trial will evaluate the efficacy of the addition of #digoxin to current HF therapies in patients with #heartfailure#HFrEF#HFmrEF, check out the design paper of this RCT: doi:10.1002/ejhf.3428
📣 On Wednesday the 5th of June, join our workshops preceding the meeting on location from the NLHI in Groningen 📍
➡️ how to survive your PhD?
➡️ storytelling in science
Spots are limited so make sure you don’t miss out!
https://t.co/V3mhliyvps
Excellent review by Antonio Esquivel Gaytan!📢We question the traditional #heartfailure management approach by showing several examples and propose a roadmap for incorporation of an integrative multi-omics approach. @CardiologyUmcg@ESC_Journals@EJHFEiC https://t.co/Fh5UUA1RH0
Proud to see our state of the art review about novel insights of PLN cardiomyopathy being published in JACC:BTS!
Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium ... https://t.co/p08HEjrDQn
Volgende week is het #NationaleHartfalenweek! Op woensdagmiddag 24 april zal het #UMCG een gratis evenement houden om aan u de verschillende aspecten van #hartfalen te laten zien. Wees welkom!
https://t.co/tgAY9LauTr